Merck Animal Health will buy Vence; Undisclosed financial terms

(RTTNews) – Merck Animal Health, a division of Merck & Co., Inc. (MRK), announced Thursday that it has signed a definitive agreement to acquire Vence from its founders and shareholders. Specific terms of the agreement were not disclosed.

Vence provides virtual fences for rotational grazing and livestock management.

The acquisition is expected to close in the third quarter of 2022, subject to customary closing conditions.

Vence, a private company, provides enhanced technology to producers and ranchers to track, monitor and manage the movement of livestock through a high-tech platform of virtual fencing solutions.

Vence technology is currently available in the United States and parts of Australia.

Rick DeLuca, President of Merck Animal Health, said, “Vence is a natural fit for Merck Animal Health’s growing animal intelligence product portfolio which includes identification, traceability and surveillance products. This new technology will give cow-calf producers the ability to track their cattle and the ability to move them from pasture to pasture. »

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.